BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
23 results:

  • 1. Promising Immunotherapy in Metastatic testicular Sex Cord Stromal Tumours After First-Line Chemotherapy.
    Shang B; Cao C; Jiang W; Shi H; Bi X; Cui C; Shou J; Zheng S; Zhang J; Zhou A; Li C; Ma J
    Front Immunol; 2021; 12():720359. PubMed ID: 35082775
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis.
    Nitta S; Kawai K; Kimura T; Kandori S; Kawahara T; Kojima T; Nishiyama H
    Int J Urol; 2021 Aug; 28(8):840-847. PubMed ID: 34085325
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical implications of the American Joint Committee on cancer (AJCC) 8th edition update in seminoma pT1 subclassification.
    Fontes-Sousa M; Lobo J; Magalhães H; Cassis J; Malheiro M; Ramos S; Henrique R; Martins A; Maurício MJ
    BMC Urol; 2020 Aug; 20(1):127. PubMed ID: 32819326
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with testicular cancer.
    Bauzá Quetglas JL; Tienza Fernández A; Bertolo R; Sabaté Arroyo XA; Guimerà García J; Tubau Vidaña V; Frontera Juan G; Pieras Ayala E
    Prog Urol; 2020 Apr; 30(5):273-280. PubMed ID: 32205060
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
    Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
    Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of incidence and histolopathological findings of soft tissue sarcomas in genitourinary tract: Uludag university experience.
    Vuruskan BA; Ozsen M; Coskun B; Yalcinkaya U
    Int Braz J Urol; 2019; 45(1):68-73. PubMed ID: 30044590
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
    Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
    Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
    Fresneau B; Orbach D; Faure-Conter C; Verité C; Castex MP; Kalfa N; Martelli H; Patte C
    Pediatr Blood Cancer; 2015 Dec; 62(12):2114-9. PubMed ID: 26206391
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.
    Fedyanin M; Tryakin A; Bulanov A; Vybarava A; Tjulandina A; Chekini D; Sekhina O; Figurin K; Garin A; Tjulandin S
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1259-64. PubMed ID: 25586890
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
    Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
    Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
    Huddart RA; Gabe R; Cafferty FH; Pollock P; White JD; Shamash J; Cullen MH; Stenning SP; ;
    Eur Urol; 2015 Mar; 67(3):534-43. PubMed ID: 25001888
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the cancer Registration Committee of the Japanese Urological Association.
    Miki T; Kamoi K; Fujimoto H; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Mikami K; Homma Y
    Int J Urol; 2014 Aug; 21(8):S1-6. PubMed ID: 24725194
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases].
    Zhang C; Wang XP; Ying ZT; Zheng W; Xie Y; Lin NJ; Ping LY; Liu WP; Deng LJ; Song YQ; Zhu J
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2209-11. PubMed ID: 24169330
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
    Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
    Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Paraneoplastic dermatomyositis associated with testicular cancer: a case report and literature review.
    Dourmishev LA; Popov JM; Rusinova D
    Acta Dermatovenerol Alp Pannonica Adriat; 2010; 19(1):39-43. PubMed ID: 20372774
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Histological features and principles of treating testicle tumors in the elderly subject].
    Camparo P; Durand X; Avances C; Culine S; Segui B; Rigaud J; ;
    Prog Urol; 2009 Nov; 19 Suppl 3():S142-6. PubMed ID: 20123499
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Resection of the inferior vena cava without reconstruction for urologic malignancies.
    Duty B; Daneshmand S
    Urology; 2009 Dec; 74(6):1257-62. PubMed ID: 19819533
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [testicular germ cell tumours: descriptive study of 13 years of experience in the health care area of Badajoz].
    Lallave Martín F; Lomas Garrido M; Laguna Alvarez E; Asuar Aydillo S; Murillo Mirat J; Ramírez Zambrana A; Molina Suarez JL
    Arch Esp Urol; 2007 Jun; 60(5):531-7. PubMed ID: 17718207
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.